Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 171 of the 172 references it cites were found in a registry or an index.

Organs-on-chips: into the next decade

Open access

Abstract

Organs-on-chips (OoCs), also known as microphysiological systems or 'tissue chips' (the terms are synonymous), have attracted substantial interest in recent years owing to their potential to be informative at multiple stages of the drug discovery and development process. These innovative devices could provide insights into normal human organ function and disease pathophysiology, as well as more accurately predict the safety and efficacy of investigational drugs in humans. Therefore, they are likely to become useful additions to traditional preclinical cell culture methods and in vivo animal studies in the near term, and in some cases replacements for them in the longer term. In the past decade, the OoC field has seen dramatic advances in the sophistication of biology and engineering, in the demonstration of physiological relevance and in the range of applications. These advances have also revealed new challenges and opportunities, and expertise from multiple biomedical and engineering fields will be needed to fully realize the promise of OoCs for fundamental and translational applications. This Review provides a snapshot of this fast-evolving technology, discusses current applications and caveats for their implementation, and offers suggestions for directions in the next decade.

Overview

CoChat Summary

## TL;DR

This review argues that organs-on-chips (OoCs, also called microphysiological systems or tissue chips) have rapidly advanced and are becoming important tools for drug discovery and development. It highlights their promise to better model human organ function and drug responses, while noting that broader realization will require solving technical and interdisciplinary challenges.

## Key findings

  • OoCs could provide insights into normal human organ function and disease pathophysiology, and more accurately predict the safety and efficacy of investigational drugs in humans.
  • The field has seen “dramatic advances” over the past decade in biology and engineering, in demonstrating physiological relevance, and in expanding applications.
  • The authors state that OoCs are likely to become useful additions to traditional preclinical cell culture methods and in vivo animal studies in the near term, and in some cases replacements in the longer term.
  • The review emphasizes that multiple biomedical and engineering disciplines will be needed to fully realize OoCs’ promise for fundamental and translational applications.

## Methods

  • This is a narrative review article, not an experimental or clinical study.
  • It synthesizes the state of the OoC field, current applications, caveats for implementation, and future directions for the next decade.
  • No original dataset, sample size, or formal statistical analysis is stated in the paper.

## Limitations

  • The paper states that the field has revealed “new challenges and opportunities,” and that caveats exist for implementation, but it does not enumerate them in the provided text.
  • Evident from the text: because this is a review, its conclusions are interpretive and depend on the underlying literature rather than new primary data (not explicitly stated as a limitation in the paper).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41573-020-0079-3

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 1 Not valid · 0 Not checked · 5 Own results and interpretations

  • Probably not a substantial claim. 2
  • It may state two separate claims as one. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 172 references

Cited by

See all 1,029

Metadata

Authors
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A.
Affiliations
  • National Institutes of Health (US)
  • Leiden University Medical Center (NL)
Corresponding author
  • Low, Lucie A.
  • Tagle, Danilo A.
Venue
Nature Reviews Drug Discovery
Published
2020-09-10
Volume
20
Issue
5
Pages
345-361
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W3084374992
Cited by
1,029
References
172
Citations by year
2026: 202 · 2025: 168 · 2024: 162 · 2023: 153 · 2022: 201 · 2021: 134 · 2020: 9
FWCI
10.39
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • University of Twente Research Information (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by)
  • University of Twente Research Information (submittedVersion, other-oa)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
Keywords
organ-on-a-chip, microphysiological systems, drug discovery, drug development, drug safety prediction, drug efficacy prediction, preclinical models, alternatives to animal testing, organ physiology, disease pathophysiology, translational research
MeSH terms
Animals, Animal Testing Alternatives, Biomedical Engineering, Cells, Cultured, Computer Simulation, Humans, Cell Culture Techniques, Microchip Analytical Procedures, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Organs-on-chips: into the next decade. https://app.cochat.ai/papers/10.1038/s41573-020-0079-3
The paper
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021). Organs-on-chips: into the next decade. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-020-0079-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.